Showing results (931-940 of 992) with videos related to

Sort By:
Pageof 100
ACS Chemical Neuroscience|January 23, 2015
Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolismPatricia Melnyk, Valérie Vingtdeux, Stéphane Burlet, et al.
BMC Medical Informatics and Decision Making|April 24, 2025
ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy managementMouazer Abdelmalek, Léguillon Romain, Boudegzdame Nada, et al.
Frontiers in Immunology|November 20, 2012
Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell researchSilvia A Fuertes Marraco, Frédéric Grosjean, Anaïs Duval, et al.
Journal of Alzheimer'S Disease : JAD|January 2, 2022
Telemedicine in French Memory Clinics During the COVID-19 PandemicAlexandre Morin, Thibaut Pressat-Laffouilhere, Marie Sarazin, et al.
Ecosystems (New York, N.Y.)|June 20, 2024
Anthropogenic Eutrophication Drives Major Food Web Changes in Mwanza Gulf, Lake VictoriaLeighton King, Giulia Wienhues, Pavani Misra, et al.
Studies in Health Technology and Informatics|August 10, 2012
RAVEL: retrieval and visualization in ELectronic health recordsFrantz Thiessard, Fleur Mougin, Gayo Diallo, et al.
BMC Anesthesiology|November 25, 2025
Compliance with ESAIC guidelines for fibrinogen concentrate prescription in cardiac surgery: a multicentre French cohort studyDan Longrois, Pierre Albaladejo, Damien Bedague, et al.
Molecular Cancer Research : MCR|February 13, 2019
Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate CancerEugenio Zoni, Letizia Astrologo, Charlotte K Y Ng, et al.
British Journal of Haematology|February 22, 2017
Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groupsAnanth G Shankar, Gaelle Roques, Amy A Kirkwood, et al.
Blood|January 9, 2014
Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitorsCaroline Marty, Cécile Saint-Martin, Christian Pecquet, et al.
Pageof 100